HOME >> MEDICINE >> NEWS
OneWorld Health licenses compounds from Yale, U of Washington to treat major parasitic diseases

San Francisco, Calif. July 8, 2003 -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, announced today it has licensed a novel class of high-potency compounds from Yale University and the University of Washington that could result in medicines for the developing and developed worlds.

The agreement gives OneWorld Health the exclusive license to develop the azole compounds to treat parasitic diseases in the developing world. OneWorld Health will initially focus on the use of the azoles in Chagas disease, the leading cause of heart failure in Latin America, where 16 to 18 million people are infected and another 100 million are at risk. The disease is most often transmitted by an insect known as the "kissing bug," but may also be transmitted by blood transfusion. At least 50,000 to 100,000 people in the U.S. are infected as well.

The licensing agreement also creates a dual market opportunity in which the universities could seek a pharmaceutical partner to develop the same compounds for fungal infections in industrialized countries.

OneWorld Health will conduct appropriate pre-clinical tests after selecting a lead candidate among the compounds, which represent the first new potential drugs to treat Chagas disease in decades. The compounds were developed by teams led by Andrew Hamilton, deputy provost for science and technology at Yale and professor of chemistry, in collaboration with Frederick Buckner, Michael Gelb, Wesley Van Voorhis, and Kohei Yokoyama, all professors at the University of Washington in Seattle.

"We are delighted that these potent anti-Chagas agents have been licensed to an organization that is committed to their development for treatment of this terrible parasitic disease," said Hamilton, of Yale. "We look forward to working with OneWorld Health to produce drug leads that will push these compounds into pre-clinical development and beyond."

"There is more optim
'"/>

Contact: Sedef Onder
sonder@thehaloproject.com
917-570-8934
Institute for OneWorld Health
8-Jul-2003


Page: 1 2 3

Related medicine news :

1. OneWorld Health begins final testing of drug to cure deadly kala azar in India
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Liverpool to lead 20M Department of Health initiative to develop medicines for children
4. Health care report cards may increase racial/ethnic disparities in bypass operations
5. 2005 Behavioral Sciences & Health Services Research Award
6. Statement on the findings of the Womens Health Study
7. Bone density returns when teens stop using Depo Provera, Group Health study finds
8. Mailman School of Public Health researchers develop infectious disease diagnostic tool
9. Health initiatives can help peace building in the Middle East
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. RelayHealth selected by Columbia University to link doctors and patients online

Post Your Comments:
(Date:5/26/2015)... 2015 Scientists at the University of ... help advanced mesothelioma patients benefit from immunotherapy; surgery may ... article on the new research. Click here to ... of thoracic surgery and pulmonology theorized that, because large ... system attack, immunotherapy drugs might work better if the ...
(Date:5/26/2015)... May 26, 2015 Adenna, Inc ... 1997, is excited to announce the launch of ... grade gloves made of polyethylene (PE) and approved by ... general applications. , The Enov8 glove might ... sandwiches or mixing salads but our proprietary formula and ...
(Date:5/26/2015)... Grants Pass, OR (PRWEB) May 26, 2015 ... nearly always fatal if not caught early. Melanoma is ... fresh water advocate Sharon Kleyne, the melanoma rate is ... solar radiation. While the melanoma risk for indoor tanning ... from these establishments. The most recent ban, in Pennsylvania, ...
(Date:5/26/2015)... Viejo, CA (PRWEB) May 26, 2015 ... styles for Final Cut Pro X . ... suspenseful to simple and elegantly styled text. , ... in seconds. , ProTrailer Network can easily complement any ... style desired and within seconds can make professional looking ...
(Date:5/26/2015)... Henderson, NV (PRWEB) May 26, 2015 ... is hosting a complimentary live online broadcast at 6:00pm ... and CEO and Trivedi Master™ Alice Branton welcomes the ... coworkers for a night of profound knowledge, transformation and ... The Trivedi Effect® and no previous knowledge, experience or ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3
(Date:5/22/2015)... The North American dental lasers market ... to reach $90.7 million by 2019, at a CAGR of ... TOC of North America Dental Lasers Market for an analysis ... tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ...   Dental lasers are specifically used in ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
Cached News: